Kathleen Tregoning's Insider Trades & SAST Disclosures
Kathleen Tregoning's most recent trade in Spero Therapeutics Inc was a trade of 20,000 Common Stock done . Disclosure was reported to the exchange on May 29, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kathleen Tregoning.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Spero Therapeutics Inc
|
Kathleen Tregoning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 20,000 | 55,000 (0%) | 0% | 0 | Common Stock | |
|
Cerevel Therapeutics Holdi...
|
Kathleen Tregoning | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 59,171 | 59,171 | - | - | Restricted Stock Units | |
|
Spero Therapeutics Inc
|
Kathleen Tregoning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 35,604 | 35,604 | - | - | Stock Option (Right to Buy) | |
|
Cerevel Therapeutics Holdi...
|
Kathleen Tregoning | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.05 per share. | 26 Dec 2023 | 3,150 | 10,666 | - | 10.1 | 31,658 | Common Stock |
|
Cerevel Therapeutics Holdi...
|
Kathleen Tregoning | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2023 | 3,150 | 255,082 | - | - | Stock Option (Right to Buy) | |
|
Cerevel Therapeutics Holdi...
|
Tregoning Kathleen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 13,804 | 13,804 | - | - | Common Stock | |
|
Cerevel Therapeutics Holdi...
|
Tregoning Kathleen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 13,804 | 0 | - | - | Restricted Stock Units | |
|
Cerevel Therapeutics Holdi...
|
Tregoning Kathleen | See Remarks | Sale of securities on an exchange or to another person at price $ 41.42 per share. | 19 Dec 2023 | 6,288 | 7,516 | - | 41.4 | 260,469 | Common Stock |
|
Cerevel Therapeutics Holdi...
|
Kathleen Tregoning | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 54,320 | 54,320 | - | - | Stock Option (Right to Buy) | |
|
Cerevel Therapeutics Holdi...
|
Kathleen Tregoning | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 13,804 | 13,804 | - | - | Restricted Stock Units | |
|
Spero Therapeutics Inc
|
Kathleen Tregoning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 30,943 | 30,943 | - | - | Stock Option (Right to Buy) | |
|
Spero Therapeutics Inc
|
Kathleen Tregoning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
|
Spero Therapeutics Inc
|
Kathleen Tregoning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 4,428 | 4,428 | - | - | Stock Option (Right to Buy) | |
|
Spero Therapeutics Inc
|
Kathleen Tregoning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
|
Cerevel Therapeutics Holdi...
|
Kathleen Tregoning | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 77,399 | 77,399 | - | - | Stock Option (Right to Buy) | |
|
Cerevel Therapeutics Holdi...
|
Kathleen Tregoning | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2020 | 78,229 | 78,229 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges